Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis

@inproceedings{Wang2014DifferentEO,
  title={Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis},
  author={Huan Wang and Jing Huang and Xiaojin Yu and Shuhua Han and Xing Yu Yan and Siqing Sun and Xiaoli Zhu},
  booktitle={Journal of Cancer Research and Clinical Oncology},
  year={2014}
}
Nearly 85 % of lung-cancer-specific epidermal growth factor receptor (EGFR) sensitive mutations comprise a substitution at position 858 (21L858R) and deletion mutants in exon 19 (19del). The aim of this study was to assess the role of EGFR mutation subtypes in predicting the efficacy of EGFR tyrosine kinase inhibitors (EGFR TKIs) and the prognosis of patients with advanced non-small cell lung cancer (NSCLC). We systematically searched for eligible articles investigating the association between… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?

Journal of Cancer Research and Clinical Oncology • 2017
View 6 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2009
View 4 Excerpts
Highly Influenced

Screening for epidermal growth factor receptor mutations in lung cancer.

The New England journal of medicine • 2009
View 5 Excerpts
Highly Influenced

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

Journal of cellular and molecular medicine • 2010
View 2 Excerpts
Highly Influenced

The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses

GA Wells, B Shea, D O’ Connell
2012
View 3 Excerpts

Similar Papers

Loading similar papers…